Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01721200 · ClinicalTrials.gov registry record · NA

"Learning About Biologics"-Rheumatoid Arthritis

A NA study of Rheumatoid Arthritis, sponsored by Geisinger Clinic.

Completed
Registry status
NA
Development phase
125
Enrollment target
1
Study location

NCT01721200 is a NA study of Rheumatoid Arthritis that has completed, run by Geisinger Clinic. The registered enrollment target is 125 participants, below the 4,690-participant average among 197 other Rheumatoid Arthritis trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01721200, a NA study of Rheumatoid Arthritis, has completed, sponsored by Geisinger Clinic.

COMPLETED
Registry status
NA
Development phase
125 participants
Enrollment target
1
Study location

Study Summary

This study is a randomized controlled trial designed to examine the efficacy of an educational decision support tool for patients with rheumatoid arthritis who continue to have active disease despite use of traditional disease modifying drugs. The study will take place at Geisinger Medical Center in Danville, PA. Eligible subjects will be identified by the treating physician and those providing consent will be randomized to usual care versus use of the decision support tool.

Conditions Studied

Interventions

  • OTHER Usual Care
  • OTHER Decision Support Tool

Study Locations (1)

Pennsylvania

  • Geisinger Medical Center - Danville

Trial Details

FieldValue
Enrollment Target 125 participants
Start Date 2012-11
Est. Completion 2015-02
Phase NA

Sponsor

Geisinger Clinic

107 total trials

What the Registry Record Tells You About NCT01721200

The ClinicalTrials.gov registry entry for NCT01721200 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 125 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,690-participant average among 197 other Rheumatoid Arthritis trials with a reported enrollment target (97% lower). The listed sponsor is Geisinger Clinic, which has 107 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Rheumatoid Arthritis appearing as the primary indexed condition, and to 2 interventions - of which Usual Care is the first listed.

NCT01721200 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT01721200 about?

NCT01721200 is a clinical study titled ""Learning About Biologics"-Rheumatoid Arthritis". This study is a randomized controlled trial designed to examine the efficacy of an educational decision support tool for patients with rheumatoid arthritis who continue to have active disease despite use of traditional disease modifying drugs. The study will take place at Geisinger Medical Center in...

What is the current status of trial NCT01721200?

This trial is currently completed. It is a NA study. The enrollment target is 125 participants. The study started on 2012-11. Estimated completion is 2015-02.

What conditions does trial NCT01721200 study?

This clinical trial studies the following conditions: Rheumatoid Arthritis.

What interventions are being tested in trial NCT01721200?

The interventions under investigation include: Usual Care (OTHER), Decision Support Tool (OTHER).

Who is sponsoring clinical trial NCT01721200?

This trial is sponsored by Geisinger Clinic, which has 107 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01721200 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Rheumatoid Arthritis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.